Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Flower

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Sensors (Basel, Switzerland)|April 3, 2021
Assessing the Capability and Potential of LiDAR for Weed DetectionNooshin Shahbazi, Michael B Ashworth, J Nikolaus Callow, et al.
International Journal of Cosmetic Science|May 22, 2008
A method for the determination of N-nitrosodiethanolamine in personal care products - collaboratively evaluated by the CTPA Nitrosamines Working GroupC Flower, S Carter, A Earls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Sensors (Basel, Switzerland)|April 3, 2021
Assessing the Capability and Potential of LiDAR for Weed DetectionNooshin Shahbazi, Michael B Ashworth, J Nikolaus Callow, et al.
International Journal of Cosmetic Science|May 22, 2008
A method for the determination of N-nitrosodiethanolamine in personal care products - collaboratively evaluated by the CTPA Nitrosamines Working GroupC Flower, S Carter, A Earls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
Pageof 4